Latest filing published 21 Sept 2026 for Mineralys Therapeutics, Inc., €182k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Warren Eric: trading record in brief
All filings by Warren Eric on record concern Mineralys Therapeutics, Inc. Over a trading history stretching from 26 June 2026 to 21 September 2026, the count stands at 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 21 September 2026 came the latest disclosure, a transaction for €182k in Mineralys Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Warren Eric
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,438 shares@ US$28.1172Common StockSEC144:0001964306-26-000453
- 7,437 shares@ US$25.97670.0081% mcap5.6% of flowCommon StockSEC144:0001964306-26-000406
- 7,438 shares@ US$26.87350.0082% mcap6.9% of flowCommon StockSEC144:0001964306-26-000324
- 104,124 shares@ US$25.89530.11% mcap100.0% of flowCommon StockSEC144:0001964306-26-000299
4 of 4 declarations
